HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Hejna Selected Research
M Hejna Research Topics
Disease
9
Neoplasms (Cancer)
01/2018 - 01/2000
3
Lymphoma (Lymphomas)
11/2004 - 12/2003
2
Neutropenia
11/2004 - 09/2001
2
Breast Neoplasms (Breast Cancer)
05/2002 - 11/2001
2
Stomatitis
11/2001 - 09/2001
2
Colorectal Neoplasms (Colorectal Cancer)
03/2001 - 09/2000
1
Cardiotoxicity
01/2018
1
Wounds and Injuries (Trauma)
10/2014
1
Renal Cell Carcinoma (Grawitz Tumor)
09/2006
1
Esophageal Neoplasms (Esophageal Cancer)
10/2005
1
Febrile Neutropenia
11/2004
1
Stomach Neoplasms (Stomach Cancer)
11/2004
1
Leukopenia
11/2004
1
T-Cell Lymphoma (Lymphoma, T Cell)
11/2004
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2004
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2003
1
Hematoma
07/2002
1
Hemarthrosis
07/2002
1
Hemorrhage
07/2002
1
Paraproteinemias (Monoclonal Gammopathy)
07/2002
1
von Willebrand Diseases (von Willebrand's Disease)
07/2002
1
Anemia
06/2002
1
Ovarian Neoplasms (Ovarian Cancer)
06/2002
1
Fatigue
06/2002
1
Prostatic Neoplasms (Prostate Cancer)
05/2002
1
Pancreatic Neoplasms (Pancreatic Cancer)
05/2002
1
Mucositis
11/2001
1
Virus Diseases (Viral Diseases)
09/2001
1
Sarcoma (Soft Tissue Sarcoma)
09/2001
1
Gallbladder Neoplasms (Gallbladder Cancer)
08/2001
1
Adenocarcinoma
03/2001
1
Erectile Dysfunction
01/2001
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2001
1
Carcinoma (Carcinomatosis)
08/2000
1
Familial primary gastric lymphoma
05/2000
1
Thrombocytopenia (Thrombopenia)
05/2000
1
B-Cell Lymphoma (Lymphoma, B Cell)
05/2000
Drug/Important Bio-Agent (IBA)
3
Fluorouracil (Carac)
FDA Link
Generic
11/2004 - 09/2000
3
Prednisone (Sone)
FDA Link
Generic
11/2004 - 12/2003
2
Vincristine (Oncovin)
FDA Link
Generic
11/2004 - 07/2004
2
Irinotecan (Camptosar)
FDA Link
Generic
11/2004 - 09/2000
2
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2004 - 07/2004
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2004 - 07/2004
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2004 - 08/2000
2
Docetaxel (Taxotere)
FDA Link
09/2001 - 08/2000
1
Trastuzumab (Herceptin)
FDA Link
01/2018
1
Epidermal Growth Factor (EGF)
IBA
01/2018
1
Monoclonal Antibodies
IBA
01/2018
1
Paraffin
IBA
10/2014
1
ErbB Receptors (EGF Receptor)
IBA
10/2011
1
Epirubicin (Ellence)
FDA Link
Generic
11/2004
1
Cisplatin (Platino)
FDA Link
Generic
11/2004
1
Etoposide (VP 16)
FDA Link
Generic
11/2004
1
taxane
IBA
11/2004
1
Rituximab (Mabthera)
FDA Link
07/2004
1
Mitoxantrone (Novantrone)
FDA Link
Generic
12/2003
1
Chlorambucil (Leukeran)
FDA Link
12/2003
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
07/2002
1
Hemoglobins (Hemoglobin)
IBA
06/2002
1
Therapeutic Uses
IBA
05/2002
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
05/2002
1
molgramostim
IBA
11/2001
1
Enzymes
IBA
11/2001
1
Povidone-Iodine (Betadine)
FDA Link
Generic
11/2001
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
11/2001
1
Thymidine
IBA
11/2001
1
Antigens
IBA
11/2001
1
Local Anti-Infective Agents (Antiseptics)
IBA
11/2001
1
Cell Adhesion Molecules
IBA
11/2001
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
11/2001
1
Amphotericin B (Amphotericin)
FDA Link
Generic
11/2001
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
11/2001
1
Protein Isoforms (Isoforms)
IBA
11/2001
1
Cytotoxins (Cytolysins)
IBA
09/2001
1
Ifosfamide
FDA Link
Generic
09/2001
1
Anthracyclines
IBA
09/2001
1
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
03/2001
1
Peptides (Polypeptides)
IBA
03/2001
1
Psychotropic Drugs (Psychoactive Drugs)
IBA
01/2001
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2001
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2001
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
09/2000
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
09/2000
1
Leucovorin (Folinic Acid)
FDA Link
09/2000
1
Gemcitabine
FDA Link
08/2000
1
Warfarin (Coumadin)
FDA Link
Generic
06/2000
1
Antibodies
IBA
01/2000
Therapy/Procedure
11
Drug Therapy (Chemotherapy)
01/2018 - 05/2000
6
Therapeutics
01/2018 - 05/2000
3
Radiotherapy
10/2005 - 08/2001
2
VAP-cyclo protocol
11/2004 - 05/2000
1
Metastasectomy
09/2006
1
Immunotherapy
09/2006
1
Neoadjuvant Therapy
10/2005
1
Aftercare (After-Treatment)
07/2004
1
Duration of Therapy
11/2001